Meet Us at JPM Week & BIO Partnering 2026

**_Accelerate Your Path to the Clinic With VeriSIM Life’s Predictive Translational AI Platform_**

This January, **VeriSIM Life’s CEO Dr. Jo Varshney and the leadership team** will be in San Francisco for the JPM Healthcare Conference and BIO One-on-One Partnering. They will be meeting with innovators, investors, and development teams looking to modernize how therapies move from concept to clinic.

## **Why Meet With the CEO and Team?**

The industry is shifting fast toward human-relevant, non-animal evidence and computational design — areas where VeriSIM Life has built deep validation across dozens of diseases.

At JPM, the CEO and team will introduce how **BIOiSIM® not only predicts translational outcomes but also _generates new, viable drug candidates_** by designing molecules that fit biological reality from the start, not just chemical rules.

BIOiSIM enables teams to:

- Generate novel molecules optimized for exposure, safety, and human biology
- Prioritize new chemical matter based on _modeled clinical viability_
- Reduce animal studies through mechanistic, explainable AI via virtual testing
- Understand toxicity, organ effects, and translational risk earlier
- Build strong IND-ready packages with explainable, human-relevant modeling
- Accelerate timelines without sacrificing confidence or scientific rigor

This is discovery and development reimagined: **molecules created with translational success built in from day one**.

## **Who Should Connect**

Teams looking to:

- Discover or design novel molecules with higher likelihood of clinical success
- Strengthen preclinical packages with model-driven, AI/mechanistic evidence
- Improve the prediction of human biology before costly studies
- Optimize formulations, delivery strategies, or dosing
- Explore integrated co-development or platform partnerships

## **Where to Meet**

**JPM Healthcare Conference – San Francisco**

**‍**

**BIO One-on-One Partnering – Available Throughout JPM Week**

## **Secure Time With the CEO and VeriSIM Life Team**

JPM Week fills quickly. Reserve time early to explore how VeriSIM Life can help you **design, evaluate, and advance novel molecules with far greater certainty** — and move programs to patients faster.